Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Stock Option Activity (Detail)

v3.24.1.u1
Stockholders' Equity - Stock Option Activity (Detail) - USD ($)
3 Months Ended 12 Months Ended
Feb. 29, 2024
Nov. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted 103,000  
Service-Based Vesting Condition Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding at November 30, 2022 404,278  
Granted 103,000  
Exercised 0  
Expired/forfeited 0  
Outstanding at February 28, 2022 507,278 404,278
Exercisable at February 28, 2023 367,868  
Outstanding at November 30, 2022, Weighted Average Exercise Price $ 7.36  
Granted, Weighted Average Exercise Price 6.31  
Exercised, Weighted Average Exercise Price 0  
Expired/forfeited, Weighted Average Exercise Price 0  
Outstanding at February 28, 2023, Weighted Average Exercise Price 7.14 $ 7.36
Exercisable at February 28, 2023, Weighted Average Exercise Price $ 7.48  
Outstanding, Weighted Average Remaining Contractual Term (Years) 4 years 4 months 6 days 4 years 5 months 26 days
Exercisable at February 28, 2023, Weighted Average Remaining Contractual Term (Years) 4 years 3 months 3 days  
Outstanding at November 30, 2022, Aggregate Intrinsic Value $ 135,330  
Granted, Aggregate Intrinsic Value 0  
Exercised, Aggregate Intrinsic Value 0  
Expired/forfeited, Aggregate Intrinsic Value 0  
Outstanding at February 28, 2023, Aggregate Intrinsic Value 113,040 $ 135,330
Exercisable at February 28, 2023, Aggregate Intrinsic Value $ 91,526